Literature DB >> 2232900

Assessment of functional gastrointestinal disease: the bowel disease questionnaire.

N J Talley1, S F Phillips, C M Wiltgen, A R Zinsmeister, L J Melton.   

Abstract

A need exists for a self-report questionnaire that reliably and accurately measures symptoms and that distinguishes patients with functional gastrointestinal disease from those with other conditions. We have developed such an instrument, the bowel disease questionnaire, and herein describe details of its discriminatory validity. Data from 399 subjects were analyzed. Patients with gastrointestinal symptoms were ultimately diagnosed as having functional gastrointestinal disease (82 with the irritable bowel syndrome and 33 with functional dyspepsia) or organic gastrointestinal disease (N = 101). There were 145 healthy control subjects and 38 patients with a psychiatric disease, somatoform disorder (which includes those with a diagnosis of hypochrondriasis, psychogenic pain, and somatization or conversion disorder). All subjects completed the questionnaire before undergoing an independent diagnostic assessment by experienced physicians. Functional gastrointestinal disease could be distinguished from organic disease, somatoform disorder, and health by using models derived from logistic discriminant analysis. With use of these models, the estimated probability of functional gastrointestinal disease was then calculated. Descriptive symptom scores were of less value than the scores derived from the data sets by logistic discriminant analysis. Age did not significantly affect the responses to the questionnaire items. We conclude that, in the population studied, the bowel disease questionnaire is a valid measure of symptoms of functional gastrointestinal disease, and this instrument may have clinical and research applications.

Entities:  

Mesh:

Year:  1990        PMID: 2232900     DOI: 10.1016/s0025-6196(12)62169-7

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  129 in total

1.  Factors associated with persistent and nonpersistent chronic constipation, over 20 years.

Authors:  Rok Seon Choung; G Richard Locke; Enrique Rey; Cathy D Schleck; Charles Baum; Alan R Zinsmeister; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

2.  Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Authors:  B S Wong; M Camilleri; D Eckert; P Carlson; M Ryks; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-01-30       Impact factor: 3.598

3.  The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection.

Authors:  Mark R Borgaonkar; David C Ford; John K Marshall; Elizabeth Churchill; Stephen M Collins
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

4.  Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.

Authors:  M Camilleri; P Carlson; S McKinzie; M Zucchelli; M D'Amato; I Busciglio; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 3.598

5.  Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert L Burr; Kevin C Cain; Vicky Hertig; Pam Weisman; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

6.  Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence.

Authors:  A E Bharucha; J G Fletcher; C M Harper; D Hough; J R Daube; C Stevens; B Seide; S J Riederer; A R Zinsmeister
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

7.  Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire.

Authors:  Rolf Leibbrand; Ulrich Cuntz; Wolfgang Hiller
Journal:  Int J Behav Med       Date:  2002

8.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

9.  First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans.

Authors:  A E Bharucha; A Kulkarni; K M Choi; M Camilleri; M Lempke; G J Brunn; S J Gibbons; A R Zinsmeister; G Farrugia
Journal:  Clin Pharmacol Ther       Date:  2009-12-02       Impact factor: 6.875

10.  Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity.

Authors:  Suwebatu T Odunsi; María I Vázquez-Roque; Michael Camilleri; Athanasios Papathanasopoulos; Matthew M Clark; Lynne Wodrich; Mary Lempke; Sanna McKinzie; Michael Ryks; Duane Burton; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2009-12-03       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.